These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6002159)

  • 21. Carcinogenic risk assessment--the consequences of believing models.
    Crouch EA
    Basic Life Sci; 1983; 24():653-65. PubMed ID: 6860280
    [No Abstract]   [Full Text] [Related]  

  • 22. IARC monograph programme on the evaluation of the carcinogenic risk of chemicals to humans: preamble.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():11-34. PubMed ID: 6944254
    [No Abstract]   [Full Text] [Related]  

  • 23. The World Health Organization defines hormone replacement therapy as carcinogenic: is this plausible?
    Mueck AO; Seeger H
    Gynecol Endocrinol; 2008 Mar; 24(3):129-32. PubMed ID: 18335326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of age in host sensitivity to carcinogens.
    Anisimov VN
    IARC Sci Publ; 1983; (51):99-112. PubMed ID: 6421731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the maternal organism in transplacental carcinogenesis.
    Alexandrov VA
    IARC Sci Publ; 1983; (51):65-79. PubMed ID: 6365774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular carcinogenic nonsense.
    Jukes TH
    Clin Toxicol; 1980 Oct; 17(3):475-6. PubMed ID: 7449360
    [No Abstract]   [Full Text] [Related]  

  • 27. Cancer and globalization.
    Sasco AJ
    Biomed Pharmacother; 2008 Feb; 62(2):110-21. PubMed ID: 18180137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The sequelae of cytochrome P-450 induction].
    Lukienko PI; Zavodnik LB; Bushma MI
    Eksp Klin Farmakol; 1995; 58(1):68-73. PubMed ID: 7787705
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cancerogenic activity of antimitotic agents in animals].
    Mazue G; Combes M
    Bull Cancer; 1983; 70(1):26-30. PubMed ID: 6839031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tobacco carcinogens, their biomarkers and tobacco-induced cancer.
    Hecht SS
    Nat Rev Cancer; 2003 Oct; 3(10):733-44. PubMed ID: 14570033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Occupational carcinogenic jeopardy and disablement due to malignancies in Moscow].
    Smulevich VB; Solenova LG; Mikhaĭlovskiĭ NIa
    Med Tr Prom Ekol; 2009; (8):5-10. PubMed ID: 19803354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chemicals and cancer risk (author's transl)].
    Schramm T; Jänisch W
    Arch Geschwulstforsch; 1981; 51(7):561-5. PubMed ID: 7337537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chemical-induced cancers].
    Bergeret A; Normand JC
    Rev Prat; 2000 Feb; 50(4):391-5. PubMed ID: 10748670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carcinogenicity of medicinal drugs: a survey of IARC monographs.
    Török G; Csík M; Pintér A; Surján A
    Cent Eur J Public Health; 2000 Jul; 8 Suppl():83-5. PubMed ID: 10943485
    [No Abstract]   [Full Text] [Related]  

  • 35. Adverse reactions and interactions with herbal medicines. Part 2--Drug interactions.
    D'Arcy PF
    Adverse Drug React Toxicol Rev; 1993; 12(3):147-62. PubMed ID: 8218717
    [No Abstract]   [Full Text] [Related]  

  • 36. Comment: drug-related problem classification systems.
    Culbertson VL
    Ann Pharmacother; 2004 Sep; 38(9):1543; author reply 1544-45. PubMed ID: 15292501
    [No Abstract]   [Full Text] [Related]  

  • 37. The increasing problem of drug reactions.
    BIRT AR
    Can Med Assoc J; 1957 Oct; 77(7):709-15. PubMed ID: 13472541
    [No Abstract]   [Full Text] [Related]  

  • 38. Comment: drug-related problem classification systems.
    Fernandez-Llimos F; Faus MJ
    Ann Pharmacother; 2004 Sep; 38(9):1542-3; author reply 1544-45. PubMed ID: 15292502
    [No Abstract]   [Full Text] [Related]  

  • 39. Comment: drug-related problem classification systems.
    Alvarez-de-Toledo F; Dago A; Eyaralar T; Gorostiza I; Salar L; Fité B
    Ann Pharmacother; 2004 Sep; 38(9):1543-4; author reply 1544-5. PubMed ID: 15292503
    [No Abstract]   [Full Text] [Related]  

  • 40. An impact analysis of the application of the threshold of toxicological concern concept to pharmaceuticals.
    Delaney EJ
    Regul Toxicol Pharmacol; 2007 Nov; 49(2):107-24. PubMed ID: 17888551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.